2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Clinical trial NCT02338960 · COMPLETED
Trial details
- NCT number
- NCT02338960
- Sponsor
- Palatin Technologies, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-08-01
- Enrollment
- 714
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.